363 related articles for article (PubMed ID: 15313300)
1. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
2. Medical control of intraocular pressure after phacoemulsification.
Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T
J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
Borazan M; Karalezli A; Akman A; Akova YA
J Cataract Refract Surg; 2007 Nov; 33(11):1941-5. PubMed ID: 17964402
[TBL] [Abstract][Full Text] [Related]
4. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
5. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification.
Kir E; Cakmak H; Dayanir V
Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
7. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
8. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
9. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.
Ermis SS; Ozturk F; Inan UU
Eye (Lond); 2005 Mar; 19(3):303-7. PubMed ID: 15258611
[TBL] [Abstract][Full Text] [Related]
10. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of dorzolamide-timolol fixed combination and brimonidine on intraocular pressure after phacoemulsification surgery.
Ozkurt Y; Oral Y; Karacan O; Comez A; Dogan OK
Eye Contact Lens; 2008 Jan; 34(1):21-3. PubMed ID: 18180678
[TBL] [Abstract][Full Text] [Related]
12. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
[TBL] [Abstract][Full Text] [Related]
13. Effect of bimatoprost on intraocular pressure after phacoemulsification in eyes with exfoliation syndrome.
Takmaz T; Can I; Gürdal C; Kürkçüoğlu P; Aşik S
Acta Ophthalmol Scand; 2007 May; 85(3):262-6. PubMed ID: 17488454
[TBL] [Abstract][Full Text] [Related]
14. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
15. [The effect of brimonidine on postoperative hypertonia after an extracapsular cataract extraction].
Katsimpris JM; Petropoulos IK; Voros G; Gerodimos G; Pharmakakis NM
J Fr Ophtalmol; 2003 Apr; 26(4):369-74. PubMed ID: 12843894
[TBL] [Abstract][Full Text] [Related]
16. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Chevrier RL; Assalian A; Duperré J; Lesk MR
Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of brimonidine 0.2% in controlling acute postoperative intraocular pressure elevation after phacoemulsification.
Katsimpris JM; Siganos D; Konstas AG; Kozobolis V; Georgiadis N
J Cataract Refract Surg; 2003 Dec; 29(12):2288-94. PubMed ID: 14709288
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
Zohdy GA; Rogers ZA; Lukaris A; Sells M; Roberts-Harry TJ
J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110
[TBL] [Abstract][Full Text] [Related]
20. Brinzolamide-brimonidine fixed combination for the prevention of intraocular pressure elevation after phacoemulsification.
Georgakopoulos CD; Kagkelaris K; Pagoulatos D; Plotas P; Makri OE
Eur J Ophthalmol; 2020 Mar; 30(2):293-298. PubMed ID: 30526051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]